Loading...

Investments In AIoT And Medical Services Will Boost Future Profitability

Published
21 Feb 25
Updated
03 Oct 25
AnalystConsensusTarget's Fair Value
NT$37.80
13.9% undervalued intrinsic discount
03 Oct
NT$32.55
Loading
1Y
-28.7%
7D
-11.5%

Author's Valuation

NT$37.813.9% undervalued intrinsic discount

AnalystConsensusTarget Fair Value

Shared on03 Oct 25
Fair value Increased 22%

Analysts have raised their price target for Qisda from $31 to approximately $37.80, citing an adjusted fair value estimate. Other core financial projections remain consistent.

Shared on17 Sep 25
Fair value Decreased 13%

The notable downward revision in Qisda’s consensus analyst price target is primarily driven by a significant decline in net profit margin and a slight decrease in future P/E, lowering fair value from NT$35.75 to NT$31.00. Valuation Changes Summary of Valuation Changes for Qisda The Consensus Analyst Price Target has significantly fallen from NT$35.75 to NT$31.00.

Shared on02 Sep 25
Fair value Increased 25%

Qisda’s higher consensus price target reflects a sharp increase in its expected future P/E ratio, signaling improved earnings growth prospects or investor confidence, raising fair value from NT$28.50 to NT$35.75. Valuation Changes Summary of Valuation Changes for Qisda The Consensus Analyst Price Target has significantly risen from NT$28.50 to NT$35.75.

Shared on01 May 25
Fair value Decreased 30%

Shared on23 Apr 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on17 Apr 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on09 Apr 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on02 Apr 25
Fair value Increased 1.41%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on26 Mar 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on19 Mar 25
Fair value Decreased 0.32%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on13 Mar 25
Fair value Increased 42%

AnalystConsensusTarget has decreased revenue growth from 6.6% to 5.1%, decreased profit margin from 3.6% to 2.3% and increased future PE multiple from 12.0x to 18.1x.